Acquisition includes HPN328, an investigational delta-like ligand 3 (DLL3) targeting T-cell engager being evaluated in certain patients with small cell lung cancer and neuroendocrine tumors
Tornado will enhance Bruker’s biopharma PAT portfolio with its well-established products
Arco Lab now holds a 50% stake in Neviton
The acquisition of the shares of Adita result in growth opportunities in line with strategic objectives of the company
Vyleesi is the first and only as-needed treatment approved by the Food and Drug Administration (FDA) for premenopausal women with acquired, generalized hypoactive sexual desire disorder (HSDD)
AMI to become part of Enpro’s Sealing Technologies Segment
Ami Organics recently announced contract with global MNC for manufacturing of electrolyte for battery cells
Roche will pay a purchase price of USD 295 million and an additional payment of up to USD 55 million
The acquisition is done through cash consideration, by way of conversion of SAFE (Simple Agreement for Future Equity) investment of US$ 2 Million to Preferred A-1 Shares
Subscribe To Our Newsletter & Stay Updated
